Patient-Reported Outcomes After Chemoradiation in Patients With Anal Cancer: A Qualitative Analysis

PURPOSE: Pelvic chemoradiation therapy (CRT) is the curative therapy for non-metastatic anal cancer, resulting in excellent survival rates. However, anal cancer survivors may experience diminished quality of life (QOL) due to late toxicities from pelvic CRT. Few studies use patient-reported QOL, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Corrigan, Kelsey L., De, Brian, Rooney, Michael K., Ludmir, Ethan B., Das, Prajnan, Smith, Grace L., Taniguchi, Cullen M., Minsky, Bruce D., Koay, Eugene J., Koong, Albert C., Holliday, Emma B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9157211/
https://www.ncbi.nlm.nih.gov/pubmed/35662810
http://dx.doi.org/10.1016/j.adro.2022.100986

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9157211/
https://www.ncbi.nlm.nih.gov/pubmed/35662810
http://dx.doi.org/10.1016/j.adro.2022.100986

Ejemplares similares